Sirio Unveils Pharmacopoeia-Grade TGA Gummies Family That Overcomes the “Impossible Triangle”

At the recent Complementary Medicines Australia (CMA) Innovation Day in Sydney, Sirio®, a well-established nutrition product solution provider, unveiled its new TGA Gummies Family.

More than a product debut, the launch underscored Sirio's expertise in manufacturing gummies to pharmacopoeia-grade standards under TGA certification. As consumers increasingly seek nutritional supplements that balance enjoyment with efficacy, Sirio is setting a new global benchmark for quality in the gummy segment.

At CMA Innovation Day, Sirio showcased its TGA Gummies Family, a comprehensive portfolio spanning multiple health categories and tailored to the diverse wellness needs of consumers across the Asia-Pacific market.

Across Asia-Pacific, particularly in Southeast Asia and Australia, consumer demand is moving beyond basic nutrition toward products that deliver targeted health benefits. Reflecting on the opportunities in this fast-growing market, Alex Du, General Manager at Sirio APAC, noted: "In a rapidly evolving market like Asia-Pacific, the speed of innovation will be a key determinant of how much market share a company can capture."

Guided by its "In Global, for Local" strategy, Sirio brings together world-class scientific validation and agile format innovation. Within Australia's rigorous TGA regulatory framework, the Company goes beyond manufacturing to deliver end-to-end solutions spanning market intelligence, regulatory compliance, nutritional product development, supply chain agility, and manufacturing capabilities, helping brands bring products to market faster and unlock growth opportunities in both local and global markets.

Elevating Nutritional Gummy Quality Through Pharmacopoeia-Grade Standards

TGA GMP certification, administered by Australia's Therapeutic Goods Administration (TGA), is widely recognized as one of the world's most stringent manufacturing quality standards. Sirio's TGA GMP-certified gummy production lines feature GMP-compliant depositing systems, rigorous cleanliness controls, and advanced precision temperature control and demolding technologies designed to accommodate complex formulations. Built to exacting international standards, these production lines enable the Company's factory in Ma'anshan to consistently manufacture gummy dosage forms with high standards of safety and batch-to-batch consistency, positioning Sirio among a select group of global manufacturers qualified to produce gummy-format complementary medicines for the Australian market.

TGA GMP certification awarded to Sirio's factory in Ma'anshan, validating compliance with one of the world's most rigorous pharmacopoeia-grade manufacturing standards and qualifying the site to produce complementary medicines for the Australian market.

These rigorous standards are embedded throughout Sirio's gummy manufacturing lifecycle, from ingredient development to post-market surveillance. With strict oversight at every stage, the Company helps ensure the safety, quality, and consistency of complex nutraceutical gummy formulations.

1. A Pharmacopoeia-Grade Threshold for Ingredient Qualification

Ingredients used in Sirio's TGA-certified products must comply with the rigorous standards of the international pharmacopoeia, including the BP, USP, and EP. Before entering production, every batch must pass comprehensive testing of physicochemical and microbial indicators to help ensure ingredient purity and quality from the very beginning of the manufacturing process.

2. High Manufacturing Standards Under PIC/S GMP

Sirio's production lines are designed and operated in accordance with PIC/S GMP, a rigorous pharmaceutical manufacturing framework established by the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Sirio employs an advanced hard-mold casting process without starch assistance, featuring ±1°C precision temperature control and custom molds with special surface treatment.

3. Moving Beyond Ingredients to Evidence-Based Nutrition

Under the TGA regulatory framework, dietary supplements may make therapeutic claims when supported by appropriate scientific evidence. Backed by a strong foundation in evidence-based science, Sirio helps transform products from ingredient-led positioning into genuinely evidence-based nutrition solutions.

Sirio's Global Gummy Solutions Overcome the Industry's "Impossible Triangle"

With 19 years of experience in nutritional gummy development and manufacturing, Sirio continues to innovate to overcome the long-standing challenge of balancing high-load, high stability, and great flavor, resulting in gummies that combine nutritional value with great taste.

1. Maximizing Nutrient Loading

Leveraging proprietary technologies and formulation expertise, Sirio continues to raise the ceiling for nutrient loading, delivering greater nutritional value in every gummy.

2. Tackling Stability Challenges

By applying specialized process technologies and rigorously controlling key manufacturing parameters, including temperature, pH, and processing time, Sirio helps ensure the long-term stability of active ingredients and sensory attributes throughout the product's shelf life.

3. Crafting Superior Sensory Experiences

With a specialized flavor laboratory dedicated to taste science and sensory analysis, Sirio combines in-house expertise with strategic partnerships with leading global flavor houses to create exceptional sensory experiences.

As regulatory expectations grow and consumer awareness continues to evolve, compliance and innovation have become indispensable to market success. Backed by TGA certification and a pharmacopoeia-grade quality system, Sirio provides brand partners with a trusted foundation for product quality and market credibility across global markets. Looking ahead, the Company will continue to empower both global and local brands through comprehensive solutions and collaborative innovation, helping shape the future of nutrition and wellness.